Jim joined Montagu Newhall Associates in October 2004. Previously he was a Director at
Commonfund Capital, a fund-of-funds firm that, as of the time of his departure, managed
nearly $5.5 billion in commitments across venture capital, private equity, international
private capital and natural resources programs. While at Commonfund Capital, Jim helped
lead the due diligence efforts on many of the firm’s top tier venture capital managers.
He also spent three years at Pfizer where he was primarily responsible for managing the
private capital portfolio of Pfizer ’s $2.5 billion pension plan. On behalf of the pension
plan, Jim made commitments to funds managed by some of the leading venture capital
and buyout managers in the industry. In addition to his pension fund experience, Jim had
several corporate finance assignments in Pfizer’s Research and Development Group and
Pfizer ’s Operational, Planning and Analysis Group.
Jim is a cum laude graduate of Washington College where he received his degree in
Economics and a graduate of Indiana University, where he received his MBA in Finance.
Jim serves on the board of Delphi Ventures, Infotech Ventures, OpenView Venture
Partners and TargetRx. Jim also is a board observer of SkinMedica, Inc., ExactTarget, Inc.,
Barrx Medical, Inc. and GlassHouse Technologies, Inc.